Navigation Links
Northrop Grumman Delivers Australian Automated Biometric Information System Trial Proof of Concept
Date:12/3/2012

MCLEAN, Va., Nov. 29, 2012 /PRNewswire/ -- Northrop Grumman Corporation (NYSE: NOC) has successfully delivered the trial proof of concept for an automated biometric information system (ABIS) for the Australian Department of Defence. The system will be operated for a trial period to enable testing and refinement of analytical techniques for producing biometrically enabled intelligence and to help determine the requirements for a future biometrics information management solution.

(Logo: http://photos.prnewswire.com/prnh/20121024/LA98563LOGO)  

A photo accompanying this release is available at http://media.globenewswire.com/noc/

"This delivery is a key step in the development of a multimodal biometric data repository for the Australian Department of Defence," said Samuel Abbate, vice president of defense enterprise solutions for Northrop Grumman's Information Systems sector. "It marks the start of a six-month trial during which biometric data will be collected, stored, matched and processed in accordance with existing legislative frameworks. ABIS will be an important element in Australian Defence Forces capability to ensure identity dominance and assurance in the theatre."

The proof of concept was delivered to the Chief Information Officer Group, Australian Department of Defence, under a one-year contract. The Australian system, which is modelled after the U.S. Department of Defense Automated Biometric Identification System (DOD ABIS), will be used to produce biometrically enabled intelligence and demonstrate the feasibility of a biometric analytic capability in the Australian Defence Force.

Northrop Grumman is the prime contractor for the DOD ABIS system, the central repository and authoritative source for the U.S. Defense D
'/>"/>

SOURCE Northrop Grumman Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. OSCs Oakley Cluster delivers on performance efficiency
2. iView Systems iTrak® version 5.5 delivers optimized Incident Reporting
3. Crestor Delivers Latest LDL-C Targets in High-Risk Patients at Lower Doses than Other Statins
4. Hunt for superbugs in Australian animals
5. Australian shipping emissions identified
6. Millipede family added to Australian fauna
7. Eyeless Australian fish have closest relatives in Madagascar
8. Aware Enables Automated Delivery of Radiation Dose Information Through Integration With Leading Radiology Reporting System
9. Cross Match Technologies Undoubtedly Offers the Highest Value to Customers in the North American Biometrics Market, Says Frost & Sullivan
10. Entrust to Address Attendees, Exhibit at ICAO Eighth Symposium and Exhibition on MRTDs, Biometrics and Security Standards
11. EyeLock Inc. Brings High-Tech Iris Biometric Production to Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... New research suggests that professional baseball pitchers with poor ... days in a single season because of injury than are ... back and pelvis. , In the study, 347 pitchers were ... tilt in their pelvis as they raised a leg to ... miss at least 30 days cumulative, not consecutive ...
(Date:9/2/2014)... the University of Warwick in the UK and the ... Journal Early Human Development , has found that ... birth and the use of mechanical ventilation are key ... Mathematic abilities are crucial for lifelong academic attainment. Impairments ... Earlier studies of children who are born very preterm ...
(Date:9/2/2014)... the most ideal source of nutrition for infants ... in the evolution and civilizations of human beings. ... large number of bacterial species, including some opportunistic ... surprise to scientists and physicians. , Indeed, the ... the result of co-evolutionary and co-adaptive interactions between ...
Breaking Biology News(10 mins):In pro baseball pitchers, weak core linked to more missed days 2In pro baseball pitchers, weak core linked to more missed days 3Mechanical ventilation a key indicator for pre-term children's math problems 2Are human breast milk microbiome 'neutral'? 2Are human breast milk microbiome 'neutral'? 3
... on labor-intensive microscopic examination, using century-old cell-staining ... and may give false readings. , A ... Laboratories researcher Paul Gourley, has provided laboratory ... liver tumor cells at their earliest stages, ...
... Canadian Network for Vaccines and Immunotherapeutics, has announced,the ... well the thymus (an organ,located at the base ... a,functional abnormality of this organ in HIV-infected individuals. ... professor at,Université de Montréal, scientist at the CHUM ...
... used to synthesize plastic food containers has been ... of prostate cancer cell,potentially affecting the treatment efficacy ... published in the January 1 issue of Cancer,Research, ... to,exposure to the chemical BPA (bisophenol A), an ...
Cached Biology News:Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells 2Novel ultrafast laser detection of cancer cells also may improve understanding of stem cells 3Estrogen-like Component of Plastic Stimulates Growth of Certain Prostate Cancer Cells 2
(Date:9/2/2014)...  Spherix Incorporated (SPEX) -- an intellectual property development company committed ... announced that the United States Patent & Trademark Office ... month of August that are part of a standard ... patents are: , U.S.RE45,065 issued August ... and , U.S.RE45,095 issued August 26, 2014.  ...
(Date:9/1/2014)... The global oligonucleotide synthesis market is expected ... million in 2014, growing at a CAGR of ... synthesis market is categorized on the basis of ... The synthesized oligonucleotides segment is expected to register ... market during the forecast period, owing to an ...
(Date:8/31/2014)... August 31, 2014 2014 ... is a professional and in-depth research report ... basic Polyacrylamide information, including Polyacrylamide definition, classification, ... as industry overview. This research covers the ... well as global industry analysis covering macroeconomic ...
(Date:8/29/2014)... but one of the most promising technologies for future ... light (photons) instead of electrons. First, it is necessary ... photons and control their direction. Researchers around the world ... control, but now scientists at the Niels Bohr Institute ... emitted one at a time and in a particular ...
Breaking Biology Technology:United States Patent & Trademark Office Issues Three New Standard Essential Patents to Spherix 29.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 29.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 39.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 49.8% CAGR for Oligonucleotide Synthesis Market Globally to 2019 Says a New Research Report Available at RnRMarketResearch.com 5International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 2International Polyacrylamide Industry & Copper Iodide Market Data Analysis Now Available at DeepResearchReports.com 3Breakthrough in light sources for new quantum technology 2
... AC Immune SA, a leader,in Alzheimer,s disease drug development, ... Immune as Technology Pioneer 2009 for its,accomplishments as an ... a deep impact on business and society. , ... that it has reached significant clinical,milestones in the development ...
... A 60-year-old,prostate cancer patient from Montpellier has become ... RapidArc(TM) technology from Varian Medical Systems,(NYSE: ... intensity modulated radiotherapy,(IMRT). Each of his treatments at ... city took just 75 seconds, several times faster ...
... Pharmaceuticals, Inc. (Nasdaq: PPHM ) today announced that it ... year 2009 on December 10, 2008 at 7:00 a.m. EST and ... at 11:30 a.m. EST on the same day. , ... results for the second quarter ended October 31, 2008 and will ...
Cached Biology Technology:Technology Pioneer 2009 - AC Immune Highlights Significant Clinical Milestones in Alzheimer's Disease Drug Development 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 2Prostate Cancer Patient in Montpellier Becomes First Cancer Patient in France Treated with Varian's RapidArc(TM) Radiotherapy 3Peregrine Pharmaceuticals to Report Second Quarter FY 2009 Financial Results 2